INN:

Class:

CTLA4 inhibitor

Adapted from Saijo N. Present status and problems on molecular targeted therapy of cancer. Cancer Res Treat. 2012 Mar; 44(1): 1-10. doi: 10.4143/crt.2012.44.1.1. Epub 2012 Mar 31.    

All content on this site is intended for healthcare professionals only. If you are a patient or carer, please visit the Lymphoma Coalition.